French Oncologist Calls Personalized Skin Cancer Vaccine ‘Real Hope’ After Moderna, Merck Trial Results

Paris: French oncologist Suzette Delaloge on Thursday described a personalized vaccine designed to prevent skin cancer recurrence as a 'real hope' after pharmaceutical companies Moderna and Merck announced promising preliminary trial results. The trea...